Product Safety Recalls

Product Recall Tracker

ZONISAMIDE Recall D-0793-2022

Description: Zonisamide Capsules, USP, 100 mg, packaged in: a) 100-count bottle (NDC 68462-130-01); b) 500-count bottle (NDC 68462-130-05), Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

ZONISAMIDE Recall D-0793-2022 Information

Mandated?Voluntary: Firm initiated
Recall NumberD-0793-2022
Event ID90029
Original Package?1
Active SubstanceZONISAMIDE
Drug RouteORAL
DistributionUSA nationwide
Quantitya) 7,044 bottles; b) 1,014 bottles
Recall ReasoncGMP deviations
Drug ClassificationClass II
Drug Code Info20220504
Product NDC68462-128 68462-129 68462-130
Product NUIN0000175753 N0000008486 M0020790
Drug UPC0368462130018 0368462128015 0368462129012
Pharma Class (PE)Decreased Central Nervous System Disorganized Electrical Activity [PE]
Pharma Class (EPC)Anti-epileptic Agent [EPC]
Pharma Class (CS)Sulfonamides [CS]
Recall Initiation Date20220425
Report Date20220504
Classification Date20220427
Address750 Corporate Dr
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient Identifier459384H98V
Drug Application NumberANDA077651
Structured Product Labeling (SPL ID)5c503c30-821e-410a-abf7-bd15bb358c11
Structured Product Labeling (SPL Set ID)fe15e56e-8b86-4a65-825c-31d37dd81612
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.